Founded in February 2018, branched out from its sister company, Sci Spec, the exclusive distributor in Thailand of the World Renowned Chromatography , Life Science Mass Spectrometry and state of the art analytic devices, Thermo Fisher Scientific since 2007. The emerging trend of “Omics” era has brought the molecular biology and advance biotechnology science upfront, widely spreading of awareness throughout academics , research and service institutions.
Lifomics focuses specifically on but not limit to Genomic applications to serve the Thai’s expert community. Being Agena Bioscience (San Diego, USA) exclusive distributor since 2015, launching and partnering the first MassARRAY the cutting edge genomic analyses, with one of the country’s prestige Medical Schools , King Chulalongkorn Memorial Hospital in precision medicine in oncology (cancers). Then, expanding through broader clinical arenas, in addition; pharmacogenomics, hereditary diseases (Cystic Fibrosis, Thalassemia), hemetologic malignancy (Chronic Myelogenous Leukemia,CML) and less invasive pregnant maternal blood screening test (Prenatal Screening).
Most recently, during the wolrd pandemic of COVID-19, the MassARRAY panel has been trusted and adopted from an advance genomic lab, Center of Medical Genomics, the affiliation of Ramathibodi Medical School Hospital, to successfully develop as surveillance tracing of the SAR CoV-2 dreaded variants panel. The unique multiplexing functionality can be tracked not only virus positivity but also detected UK , South Africa, Brazil & Indian variants in a single run.
Serving unmet need and resolve pain points in Agricultural Genomic (plants & animals) of the Country, the Company engages a top key opinion leader in National Omics Center, the affiliation of National Science and Technology Development Agency (NSTDA), to adopt high throughput of MassARRAY technology in genomic services for academic institutions and agricultural businesses. The most highlighted translational service, is to conversing endangered wild animal, the DNA barcoding of Thai’s forest tigers project.
Since Thailand is one of the imported countries of meat products, Food Safety is considered as top priority, the Company invests and builds collaboration with Biotech’s expert on R&D, to pilot design “pathogen panel” running on MassARRAY platform. The de novo alternative screening test of multi-bacterial strains contamination without traditional microbiological culture.
Streamlining the genomics solution is essential, hence Lifomics commits to bridge all gaps, in 2017, the exclusive distributor agreement was signed with LGC group, the exdistinguished UK National Measurement Lab for over 100 years and later was privatised since 1996. One of the most breakthrough contribution to the Thai’s society are the installation of high throughput IntelliQube, the world’s quickly and flexibly fully automated high-throughput multiplexing qPCR system and the first oligonucleoside synthezer, the MerMade at Biotech and National Omics Center.
Later LGC group was then integrated with Lucigen, the US based company, whose core speciality are enzyme evolution, protein expression, cloning,competent cells, next generation sequencing, and molecular diagnostics. The global synergistic integration becomes brooding genomic total solution entitled “Biosearch Technologies” Lifomics dedicates all its best, to bring world advanced technologies, bridge the unmet needs gap, and becoming professional partner with all clinical genomics , agrigenomics, academic researchers, scientists and both local and global business enterprises, to translate omics knowledge to real life applications.